» Articles » PMID: 18557965

Multidrug-resistant Gram-negative Bacteria in a Long-term Care Facility: Prevalence and Risk Factors

Overview
Specialty Geriatrics
Date 2008 Jun 19
PMID 18557965
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To quantify the prevalence, risk factors, and mode of transmission associated with colonization by multidrug-resistant gram-negative bacteria (MDRGN) in the long-term care (LTC) setting.

Design: Cross-sectional.

Setting: Four nursing units in a 648-bed LTC facility in Boston, Massachusetts.

Participants: Eighty-four long-term care residents.

Measurements: Nasal and rectal swabs were obtained to determine colonization with MDRGN; if present, molecular typing was performed. The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) was also determined. Demographic and clinical characteristics were obtained from the medical record. Multivariable analysis was used to identify factors independently associated with MDRGN colonization.

Results: A total of 51%, 28%, and 4% subjects were colonized with MDRGN, MRSA, and VRE, respectively. After multivariable adjustment, advanced dementia (adjusted odds ratio (AOR)=2.9, 95% confidence interval (CI)=1.2-7.35, P=.02) and nonambulatory status (AOR=5.7, 95% CI=1.1-28.9, P=.04) were the only independent risk factors for harboring MDRGN. Molecular typing indicated person-to-person transmission.

Conclusion: Colonization with MDRGN is common in the LTC setting. A diagnosis of advanced dementia is a major risk factor for harboring MDRGN.

Citing Articles

Antimicrobial Agent Use for Urinary Tract Infection in Long-Term Care Facilities in Spain: Results from a Retrospective Analytical Cohort Analysis.

Matovelle P, Olivan-Blazquez B, Magallon-Botaya R, Garcia-Sangenis A, Monfa R, Morros R Antibiotics (Basel). 2024; 13(2).

PMID: 38391537 PMC: 10885965. DOI: 10.3390/antibiotics13020152.


Role of multidrug-resistant bacteria in weaning from invasive mechanical ventilation.

Michels-Zetsche J, Gassmann V, Jasuja J, Neetz B, Hoger P, Meis J Respir Res. 2024; 25(1):69.

PMID: 38317197 PMC: 10840161. DOI: 10.1186/s12931-024-02694-5.


Oh my gut! Is the microbial origin of neurodegenerative diseases real?.

Walker A, Czyz D Infect Immun. 2023; 91(10):e0043722.

PMID: 37750713 PMC: 10580905. DOI: 10.1128/iai.00437-22.


Rapid In Vitro Assessment of Antimicrobial Drug Effect Bridging Clinically Relevant Pharmacokinetics: A Comprehensive Methodology.

Nikolaou M, Tam V Pharmaceutics. 2023; 15(6).

PMID: 37376120 PMC: 10305065. DOI: 10.3390/pharmaceutics15061671.


SIMULTANEOUS IN VITRO SIMULATION OF MULTIPLE ANTIMICROBIAL AGENTS WITH DIFFERENT ELIMINATION HALF-LIVES IN A PRE-CLINICAL INFECTION MODEL.

Kesisoglou I, Eales B, Ledesma K, Merlau P, Tam V, Wang W Comput Chem Eng. 2021; 155.

PMID: 34924641 PMC: 8682276. DOI: 10.1016/j.compchemeng.2021.107540.